Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Housing & Urban Development Corporation Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Robust pipeline with committed liabilities exceeding INR 1.2 lakh crores supports continued growth. Key concall takeaways from Housing & Urban Development…
8 Aug 2026
Endurance Technologies Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
European subsidiaries grew revenues by 16.1% and EBITDA by 22.1% despite a challenging market (Page 4). Key concall takeaways from Endurance Technologies Ltd's…
8 Aug 2026
PNB Housing Finance Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Retail loan book grew 17% YoY; total loan book growth at 15% YoY as of Q2. Key concall takeaways from PNB Housing Finance Ltd's Q2 FY26 earnings call — and how…
8 Aug 2026
ERIS Lifesciences Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
International business delivered 45% revenue growth in Q3, with strong visibility for FY27 revenue between INR 550-600 crores. Key concall takeaways from ERIS…
8 Aug 2026
Shankara Building Products Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Strong volume growth in steel business with a 35% year-on-year increase in Q1, indicating good demand. Key concall takeaways from Shankara Building Products…
8 Aug 2026
BSE Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
15,000 crores reported. Key concall takeaways from BSE Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
8 Aug 2026
Dr Lal Pathlabs Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Sustained 11%-12% revenue growth without price hikes is planned, driven by increased patient volume and revenue per patient. Key concall takeaways from Dr Lal…
8 Aug 2026
Healthcare Global Enterprises Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
FY '25 revenue grew 16% to INR 2,223 crores; Q4 revenue rose 18% YoY to INR 585 crores. Key concall takeaways from Healthcare Global Enterprises Ltd's Q4 FY25…
8 Aug 2026
Alkem Laboratories Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
CDMO business are around INR 15-20 crores, with operating expenses at approximately INR 50 crores per quarter as ramp-up continues. Key concall takeaways from…
8 Aug 2026
Interglobe Aviation Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Load factors remain robust (~85%), with IndiGo outperforming competitors domestically and internationally due to network strength and smart pricing. Key…
8 Aug 2026
Laurus Labs Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
2,500 to 3,000 crores. Key concall takeaways from Laurus Labs Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
8 Aug 2026
Thyrocare Technologies Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Franchise revenue grew 24% YoY, partnerships business grew 23% YoY, and radiology business increased 13% YoY. Key concall takeaways from Thyrocare Technologies…
8 Aug 2026
RBL Bank Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Net advances grew 13% YoY; retail advances grew 19% YoY; secured retail advances up 38% YoY, indicating growth focus on secured retail and wholesale segments…
8 Aug 2026
Parag Milk Foods Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
ROCE has improved from 8.6% to 14.3%, reflecting better profitability and capital efficiency. Key concall takeaways from Parag Milk Foods Ltd's Q3 FY26…
8 Aug 2026
ICICI Prudential Life Insurance Company Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Q1 growth was impacted by a high base last year (35%+ growth in Q1 FY2025) and softer ULIP demand and regular annuity premiums this year. Key concall takeaways…
8 Aug 2026
Quess Corp Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Professional Staffing to exit the quarter with INR30 crores EBITDA run rate, reflecting shift towards higher value and higher-margin work. Key concall…
8 Aug 2026
Power Mech Projects Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
New initiatives in township construction with an INR972 crores order in Telangana. Key concall takeaways from Power Mech Projects Ltd's Q4 FY25 earnings call…
8 Aug 2026
Advanced Enzyme Technologies Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Mukund Kabra and other executives focus on discussing sales trends, capacity utilization (~55-60%), and organic growth challenges. Key concall takeaways from…
8 Aug 2026
AvenuesAI Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
EBITDA showed a 25% year-over-year increase, with improved operating leverage as volumes scale. Key concall takeaways from AvenuesAI Ltd's Q3 FY26 earnings…
8 Aug 2026
AvenuesAI Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Strong sequential and year-on-year growth reported: gross revenue up 53% sequentially and 93% YoY; net revenue up 14% YoY. Key concall takeaways from AvenuesAI…
8 Aug 2026